Immediate Impact

34 from Science/Nature 65 standout
Sub-graph 1 of 21

Citing Papers

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Pan-cancer whole-genome comparison of primary and metastatic solid tumours
2023 StandoutNature
4 intermediate papers

Works of Tim Demuth being referenced

Encorafenib (Lgx818), an Oral Braf Inhibitor, in Patients (Pts) with Braf V600E Metastatic Colorectal Cancer (Mcrc): Results of Dose Expansion in an Open-Label, Phase 1 Study
2014
Glioma Cell Motility is Associated with Reduced Transcription of Proapoptotic and Proliferation Genes: A cDNA Microarray Analysis
2001
and 3 more

Author Peers

Author Last Decade Papers Cites
Tim Demuth 1983 1159 608 623 43 3.2k
Tatsuya Ozawa 1697 1021 1346 1148 46 3.4k
Svetlana Kotliarova 2159 1167 1156 874 26 3.6k
Johanna Lahdenranta 1981 1363 360 615 47 3.6k
Brett L. Carlson 1870 1242 1422 708 67 3.5k
Claudia Petritsch 2749 1033 871 1797 37 4.3k
Igor Garkavtsev 2878 1198 405 1140 32 4.0k
Michal O. Nowicki 2336 768 647 1341 53 3.7k
Chengkai Dai 2538 714 989 656 31 3.6k
Hiroaki Okuyama 2594 1756 527 1794 57 5.0k
Frits Thorsen 1620 943 1184 955 84 3.9k

All Works

Loading papers...

Rankless by CCL
2026